rs886037629
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_207346.3(TSEN54):c.1172_1185del(p.Gln391ProfsTer39) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. V390V) has been classified as Likely pathogenic. Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Consequence
TSEN54
NM_207346.3 frameshift
NM_207346.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.01
Genes affected
TSEN54 (HGNC:27561): (tRNA splicing endonuclease subunit 54) This gene encodes a subunit of the tRNA splicing endonuclease complex, which catalyzes the removal of introns from precursor tRNAs. The complex is also implicated in pre-mRNA 3-prime end processing. Mutations in this gene result in pontocerebellar hypoplasia type 2.[provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-75522250-TGCAGAGGAGCCAGC-T is Pathogenic according to our data. Variant chr17-75522250-TGCAGAGGAGCCAGC-T is described in ClinVar as [Pathogenic]. Clinvar id is 30751.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSEN54 | NM_207346.3 | c.1172_1185del | p.Gln391ProfsTer39 | frameshift_variant | 8/11 | ENST00000333213.11 | NP_997229.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSEN54 | ENST00000333213.11 | c.1172_1185del | p.Gln391ProfsTer39 | frameshift_variant | 8/11 | 1 | NM_207346.3 | ENSP00000327487 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 07, 2023 | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 30751). This variant is also known as c.1170_1183del. This premature translational stop signal has been observed in individual(s) with pontocerebellar hypoplasia (PMID: 20956791). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln391Profs*39) in the TSEN54 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TSEN54 are known to be pathogenic (PMID: 18711368, 20952379). - |
Pontocerebellar hypoplasia type 4 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 19, 2010 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at